Fitbit®-derived evidence of enhanced mobility of patients with knee osteoarthritis treated with triamcinolone acetonide extended release: Results from a phase 3B, single-ARM, open-label study. Issue 1 (April 2020) - Huffman, K.M.; Spitzer, A.; Richmond, J.C.; Gomoll, A.; Kraus, V.B.; Jones, D.G.; Concoff, A.; Cinar, A.; Kelley, S.